Skip to main content
HCPCS J1817 · Level II · Part B drug

J1817: insulin for administration (Humilin R, Humalog, Humalog Tempo Pen), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1817

Billing unit
50 UNITS
Insulin for insulin pump use
ASP payment limit
$3.116
October 2026; +1.8% vs July 2026
Practitioner MUE
0
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1817 is the Level II code for Insulin for administration through dme (i.e., insulin pump) per 50 units, billed per 50 UNITS. The Medicare Part B ASP payment limit for October 2026 is $3.116 per billing unit, up 1.8% from July 2026. The practitioner MUE allows up to 0 units per date of service (MAI 3). Under OPPS it carries status indicator N. J1817 is billed in units of 50 UNITS; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 31 NDCs to it, sold as Humilin R, Humalog, Insulin Lispro by Eli Lilly and Company, Sanofi-Aventis U.S. LLC, Novo Nordisk, Inc. No current Billing and Coding Article lists J1817, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1817 at $3.116 per 50 UNITS for October 2026, derived from manufacturer average sales price plus 6%, compared with $3.062 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1817
QuarterPayment limitPerCoinsurance
October 2026$3.11650 UNITS20%
July 2026$3.06250 UNITS—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 31 NDCs from 4 labelers to J1817. Report the NDC in the claim's drug segment and bill the number of J1817 units that equals the quantity administered divided by 50 UNITS; the last column gives units per full package.

NDCs that crosswalk to J1817
NDCDrug nameLabelerPackage sizeBilling units / package
00002-0213-01Humilin REli Lilly and Company3 × 16
00002-7510-01HumalogEli Lilly and Company10 × 120
00002-7510-17HumalogEli Lilly and Company3 × 16
00002-7516-59HumalogEli Lilly and Company3 × 530
00002-7533-01HumalogEli Lilly and Company3 × 16
00002-7737-01Insulin LisproEli Lilly and Company10 × 120
00002-7752-05Insulin Lispro Junior KwikpenEli Lilly and Company3 × 530
00002-8213-05Humalog Tempo PenEli Lilly and Company3 × 530
00002-8215-01Humulin REli Lilly and Company10 × 120
00002-8215-17Humulin REli Lilly and Company3 × 16
00002-8222-59Insulin Lispro KwikpenEli Lilly and Company3 × 530
00002-8501-01Humulin REli Lilly and Company20 × 1200
00002-8799-59Humalog KwikpenEli Lilly and Company3 × 530
00024-5924-10AdmelogSanofi-Aventis U.S. LLC10 × 120
00024-5925-05AdmelogSanofi-Aventis U.S. LLC3 × 530
00024-5926-05AdmelogSanofi-Aventis U.S. LLC3 × 16
00088-2500-33ApidraSanofi-Aventis U.S. LLC10 × 120
00169-2100-11insulin aspartNovo Nordisk, Inc10 × 120
00169-2101-25insulin aspartNovo Nordisk, Inc3 × 530
00169-3303-12Novolog PenfillNovo Nordisk, Inc3 × 530
00169-6339-10Novolog FlexpenNovo Nordisk, Inc3 × 530
00169-7501-11NovologNovo Nordisk, Inc10 × 120
50090-0352-00Humulin NA-S Medication Solutions10 × 120
50090-0353-00Humulin RA-S Medication Solutions10 × 120
50090-0497-00Novolin RA-S Medication Solutions10 × 120
50090-0498-00Novolin NA-S Medication Solutions10 × 120
50090-1375-00HumalogA-S Medication Solutions10 × 120
50090-1664-00NovologA-S Medication Solutions10 × 120
50090-1678-00Novolog FlexpenA-S Medication Solutions3 × 530
50090-4956-00Insulin AspartA-S Medication Solutions3 × 530
50090-5391-00Insulin LisproA-S Medication Solutions10 × 120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1817. For practitioners the limit is 0 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1817 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services03 Date of Service Edit: ClinicalCMS Policy
Facility outpatient hospital03 Date of Service Edit: ClinicalCMS Policy
DME supplier2703 Date of Service Edit: ClinicalPrescribing Information

MUE for J1817 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J1817 is 100 units for DME supplier claims (Medicare: 270). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1817 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1817 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1817 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1817 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Local coverage policies that list J1817

1 active Local Coverage Determination lists J1817 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1817 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1817 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1817 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1817

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1817

What does HCPCS code J1817 describe?

J1817 is defined by CMS as "Insulin for administration through dme (i.e., insulin pump) per 50 units". Each billing unit represents 50 UNITS, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1817 a CPT code?

No. J1817 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as insulin for administration; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1817 reports the drug itself in 50 units units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1817 in October 2026?

The ASP-based payment limit is $3.116 per 50 UNITS, with 20% beneficiary coinsurance. The July 2026 limit was $3.062. Commercial payers use their own fee schedules.

How many units of J1817 can be billed per day?

The practitioner Medically Unlikely Edit is 0 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "CMS Policy" as the rationale.

Which NDCs map to J1817?

The October 2026 ASP crosswalk lists 31 NDCs from 4 labelers: Humilin R (Eli Lilly and Company); Humalog (Eli Lilly and Company); Insulin Lispro (Eli Lilly and Company); Insulin Lispro Junior Kwikpen (Eli Lilly and Company). For example NDC 00002-0213-01 (package size 3) equals 6 billing units of J1817.

Does J1817 have NCCI bundling edits?

No active practitioner PTP pairs list J1817 as a column-1 or column-2 code in the v323r0 release.

CMS guidance

The Medicare Learning Network publication that CMS issues on this topic, cited by ICN and publication date:

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.